Sophie Langenskiöld
Senior Lecturer/Associate Professor at Institutionen för medicinska vetenskaper; Hälsoekonomi
- Telephone:
- +46 70 939 37 33
- Mobile phone:
- +46 70 939 37 33
- E-mail:
- sophie.Langenskiold@medsci.uu.se
- Visiting address:
- Epihubben, MTC-huset, Dag Hammarskj
SE-751 85 Uppsala
Sweden - Postal address:
- Epihubben, MTC huset
SE-751 85 Uppsala
Sweden
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
I have long held a strong interest in the methodology of causal inference. During my doctoral studies, I found these econometric and statistical methods even more intriguing than my wider area of specialization, the economics of health and health policy. After my work at AstraZeneca, however, I have been drawn again to the depth and promise of health economics. Now, equipped with a broader skill set and valuable experience from the private sector, I am eager to pursue an academic career.
Publications
Recent publications
- Novel hormonal therapy versus standard of care (2024)
- Causal inferences and real-world evidence (2023)
- Economic Consequences of Surgery for Adhesive Small Bowel Obstruction (2023)
- Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System (2022)
- Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI Trial (2021)
All publications
Articles
- Novel hormonal therapy versus standard of care (2024)
- Causal inferences and real-world evidence (2023)
- Economic Consequences of Surgery for Adhesive Small Bowel Obstruction (2023)
- Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System (2022)
- Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction-Insights From the Randomized DETO2X-AMI Trial (2021)
- Study protocol for a comparative effectiveness evaluation of abiraterone acetate against enzalutamide (2021)
- Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China (2020)
- Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making (2020)
- Depressive disorders in adolescence, recurrence in early adulthood, and healthcare usage in mid-adulthood (2019)
- Indicated preventive interventions for depression in children and adolescents (2019)
- How psychological distance of a study sample in discrete choice experiments affects preference measurement (2019)
- Research participants' preferences for receiving genetic risk information (2019)
- Nurse-led clinic for patients with liver cirrhosis-effects on health-related quality of life (2018)
- Indicated Preventive Interventions for Depression in Children and Adolescents (2018)
- Making sense of genetic risk (2018)
- What is the right profile for getting a job? (2017)
- Indicated preventive interventions for depression in Children and Adolescents (2017)
- How Robust are Economic Evaluations of Parenting Programs for Managing Conduct Disorder? (2017)
- Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden (2016)
- Freedom of Choice about Incidental Findings can frustrate participants’ true preferences (2016)
- Evidensbaserad vård även för de allra äldsta, tack! (2015)
- Milk intake and risk of mortality and fractures in women and men (2014)
- Incidental findings (2014)
- Vad är värst - dålig hälsa, utländsk bakgrund eller 55+? (2013)
- Outcome-free Design of Observational Studies (2008)
- A study protocol for a comparative effectiveness evaluation of antiandrogenic medications against Standard of Care
Chapters
Reports
